Literature DB >> 4917967

A rating scale for extrapyramidal side effects.

G M Simpson, J W Angus.   

Abstract

Mesh：

Substances：

Year:  1970        PMID： 4917967     DOI： 10.1111/j.1600-0447.1970.tb02066.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand Suppl        ISSN： 0065-1591


× No keyword cloud information.
  674 in total

1.  Novelty-elicited mismatch negativity in patients with schizophrenia on admission and discharge.

Authors:  I Grzella; B W Müller; R D Oades; S Bender; U Schall; D Zerbin; J Wolstein; G Sartory
Journal:  J Psychiatry Neurosci       Date:  2001-05       Impact factor: 6.186

2.  Assessment of drugs in schizophrenia. Asessment of drug-induced extrapyramidal reactions and of drugs given for their control.

Authors:  R H Mindham
Journal:  Br J Clin Pharmacol       Date:  1976-06       Impact factor: 4.335

3.  Work performance versus clinical assessment in the evaluation of phenothiazine therapy.

Authors:  P Harper; C Chacon
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335

Review 4.  Revisiting the Concept of Subjective Tolerability to Antipsychotic Medications in Schizophrenia and its Clinical and Research Implications: 30 Years Later.

Authors:  A George Awad
Journal:  CNS Drugs       Date:  2019-01       Impact factor: 5.749

Review 5.  Zotepine versus other atypical antipsychotics for schizophrenia.

Authors:  Selvizhi Subramanian; Christine Rummel-Kluge; Heike Hunger; Franziska Schmid; Sandra Schwarz; Werner Kissling; Stefan Leucht; Katja Komossa
Journal:  Cochrane Database Syst Rev       Date:  2010-10-06

6.  Rasagiline in the Treatment of the Persistent Negative Symptoms of Schizophrenia.

Authors:  Robert W Buchanan; Elaine Weiner; Deanna L Kelly; James M Gold; William R Keller; James A Waltz; Robert P McMahon; David A Gorelick
Journal:  Schizophr Bull       Date:  2014-11-02       Impact factor: 9.306

Review 7.  Assessment in multisite randomized clinical trials of patients with autistic disorder: the Autism RUPP Network. Research Units on Pediatric Psychopharmacology.

Authors:  L E Arnold; M G Aman; A Martin; A Collier-Crespin; B Vitiello; E Tierney; R Asarnow; F Bell-Bradshaw; B J Freeman; P Gates-Ulanet; A Klin; J T McCracken; C J McDougle; J J McGough; D J Posey; L Scahill; N B Swiezy; L Ritz; F Volkmar
Journal:  J Autism Dev Disord       Date:  2000-04

8.  Measurement of quality of life in schizophrenia: a comparison of two scales.

Authors:  Yvette Kusel; Richard Laugharne; Sian Perrington; Jan McKendrick; Deborah Stephenson; J Stockton-Henderson; Madeline Barley; R McCaul; Tom Burns
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2007-08-29       Impact factor: 4.328

9.  Addition of lithium to haloperidol in non-affective, antipsychotic non-responsive schizophrenia: a double blind, placebo controlled, parallel design clinical trial.

Authors:  W H Wilson
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

10.  Modelling and forecasting Positive and Negative Syndrome Scale scores to achieve remission using time series analysis.

Authors:  Alka Sabharwal; Gurprit Grover; Sakshi Kaushik; K E Sadanandan Unni
Journal:  Int J Methods Psychiatr Res       Date:  2019-01-16       Impact factor: 4.035
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.